How to access and determine the severity and complications of small bowel Crohn’s disease
Earn CME for related activities: https://www.naccme.com/gastro
In this presentation from the Clinical Track at the 2017 Advances in Inflammatory Bowel Diseases conference, Dr. Asher Kornbluth discusses how to access and determine the severity and complications of small bowel Crohn’s disease.
© 2017 Imedex, LLC.
Видео How to access and determine the severity and complications of small bowel Crohn’s disease канала HMP Education
In this presentation from the Clinical Track at the 2017 Advances in Inflammatory Bowel Diseases conference, Dr. Asher Kornbluth discusses how to access and determine the severity and complications of small bowel Crohn’s disease.
© 2017 Imedex, LLC.
Видео How to access and determine the severity and complications of small bowel Crohn’s disease канала HMP Education
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![Practical Application of Negative Pressure Wound Therapy with Instillation](https://i.ytimg.com/vi/QOcaf9bXnO0/default.jpg)
![Segment 2: Risk Assessment in Prostate Cancer](https://i.ytimg.com/vi/KyX7sHlyxxY/default.jpg)
![Rectal cancer: What is next in the field of radiotherapy?](https://i.ytimg.com/vi/7REiU7MrXAo/default.jpg)
![Improving Outcomes in Atrial Fibrillation with Optimal Antiarrhythmic Approaches](https://i.ytimg.com/vi/6RfnuaNkKgI/default.jpg)
![Virtual Patient Case: Carcinoid Syndrome #1 - Initial Presentation](https://i.ytimg.com/vi/clBO7vMCw5U/default.jpg)
![What Determines “Quality” for Endoscopy Reporting in IBD Patients?](https://i.ytimg.com/vi/H1Jeasq3VBc/default.jpg)
![Current and Evolving Therapeutic Landscape of IBD](https://i.ytimg.com/vi/w9yg0IaH-2w/default.jpg)
![Molecular Alterations and New Drugs in Bile Duct Cancer](https://i.ytimg.com/vi/5xNZebrS6UM/default.jpg)
![Multiple Myeloma Update: Maintenance Therapy](https://i.ytimg.com/vi/avcBnYXdf00/default.jpg)
![Optimizing IBD Management: New and Emerging Therapeutic Targets](https://i.ytimg.com/vi/d_IpfzI6ZRs/default.jpg)
![Can We Increase the Immunogenicity in MSS CRC?](https://i.ytimg.com/vi/zJsk1VYx4_M/default.jpg)
![Optimizing Biological Therapies in the Modern Era](https://i.ytimg.com/vi/vljkYPnDNG4/default.jpg)
![Key Insights in Chronic Lymphocytic Leukemia](https://i.ytimg.com/vi/-eJhDFbEIYY/default.jpg)
![Hydroxyurea Intolerance/Resistance in Polycythemia vera](https://i.ytimg.com/vi/wxPQTx9VIhw/default.jpg)
![Acute Myeloid Leukemia: Panel Discussion](https://i.ytimg.com/vi/VJ4zL-tSYv0/default.jpg)
![Do We Know the Cause(s) of IBD: Update on the Microbiome with the RISK Study as a Model](https://i.ytimg.com/vi/NpPOf6FEk40/default.jpg)
![What is New in Waldenström Macroglobulinemia? How I Treat it](https://i.ytimg.com/vi/uifHtNR0wHE/default.jpg)
![ADHD: Essential Tools for Recognizing and Treating Patients From Young Adulthood and Beyond](https://i.ytimg.com/vi/CVXTSnFKbno/default.jpg)
![Immune Function in CLL: What is Wrong and Why?](https://i.ytimg.com/vi/yzTRCAcf2Ek/default.jpg)
![MRD in Acute Myeloid Leukemia](https://i.ytimg.com/vi/WwA43uzHXqY/default.jpg)
![Migraine Prevention: New Opportunities for Pain Relief](https://i.ytimg.com/vi/_2BxX_GHR9g/default.jpg)